Diabetes and thyroid hormones affect connexin-43 and PKC-ε expression in rat heart atria

Physiological Research

Volumn 58, Issue 2, 2009, Pages 211-217

  Mitasikova M ^a   Lin, H ^b   Soukup, T ^c   Imanaga, I ^b   Tribulova N ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b FUKUOKA UNIVERSITY   (Japan)

^c INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Atrial fibrillation; Connexin 43; Diabetes; PKC ; Rat heart atria; Triiodothyronine

Indexed keywords

CONNEXIN 43; LIOTHYRONINE; PROTEIN KINASE C EPSILON;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART MUSCLE; HYPERTHYROIDISM; MALE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; RAT; SUPRAVENTRICULAR TACHYCARDIA; UPREGULATION; WISTAR KYOTO RAT;

ANIMALS; ATRIAL FIBRILLATION; BLOOD GLUCOSE; CONNEXIN 43; DIABETES MELLITUS, EXPERIMENTAL; HEART ATRIA; HYPERTHYROIDISM; MALE; MYOCARDIUM; PHOSPHORYLATION; PROTEIN KINASE C-EPSILON; RATS; RATS, INBRED WKY; TACHYCARDIA, SUPRAVENTRICULAR; TRIIODOTHYRONINE; UP-REGULATION;

EID: 66349103649     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bowling N, Huang X, Sandusky GE: Protein kinase C-α and ε modulate connexin43 phosphorylation in human heart. J Mol Cell Cardiol 33: 789-798, 2002.
2. Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI: Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol 39: 366-372, 2002.
3. Dhein S, Polontchouk L, Salameh A, Haefliger JA: Pharmacological modulation and differential regulation of the cardiac gap junction proteins connexin43 and connexin40. Biol Cell 94: 409-422, 2002.
4. Doble PW, Ping P, Kardami E: The ε subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ Res 86: 293-301, 2000.
5. Ferrer T, Gallego M, Madrigal-Quinonez M: DITPA restores the repolarizing potassium currents Itof and Iss in cardiac ventricular myocytes of diabetic rats. Life Sci 79: 883-889, 2006.
6. Hamasaki Y, Shinohara O, Ishida H, Hayashi Y, Nakazawa H: Decreased protein kinase C-epsilon expression in hypertrophied cardiac ventricles induced by triiodothyronine treatment in the rat. Life Sci 67: 1859-1868, 2000.
7. Inoguchi T, Hai Yan Yu, Imamura M: Altered gap junction activity in cardiovascular tissues of diabetes. Med Electron Microsc 34: 86-91, 2001.
8. Kanagaratnam P, Dupont E, Rothery S, Coppen S, Severs NJ, Peters NS: Human atrial conduction and arrhythmogenesis correlates with conformational exposure of specific epitopes on the connexin40 carboxyl tail. J Mol Cell Cardiol 40: 675-687, 2006.
9. Kanno S, Saffitz JE: The role of myocardial gap junctions in electrical conduction and arrhythmogenesis. Cardiovasc Pathol 10: 79-91, 2001.
10. Knezl V, Soukup T, Okruhlicová L, SlezáK J, Tribulová N: Thyroid hormones modulate occurrence and termination of ventricular fibrillation by both long-term and acute actions. Physiol Res 57 (SUPPL 2): S91-S96, 2008.
11. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J: Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 54: 361-379, 2002.
12. Kuroki T, Inoguchi T, Umeda F, Ueda F, Nawata H: High glucose induces alterations of gap junction permeability and phosphorylation of connexion-43 in cultured aortic smooth muscle cells. Diabetes 47: 931-936, 1998.
13. Lampe PD, Tenbroek EM, Burt JM, Kurata WE, Johnson EG, Lau AF: Phosphorylation of connexine43 on serine368 by protein kinase C regulates gap junctional communication. J Cell Biol 149: 1503-1512, 2000.
14. Lin H, Ogawa K, Imanaga I, Tribulová N: Remodeling of connexin 43 in the diabetic rat heart. Mol Cell Biochem 290: 69-78, 2006.
15. Miyasaka Y, Barnes ME, Gersh BJ, Cha SS, Bailey KR, Abhayaratna WP, Seward JB, Tsang TS: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114: 119-125, 2006.
16. Olsson SB: Atrial fibrillation-where do we stand today? J Intern Med 250: 19-28, 2001
17. Polontchouk L, Haefliger JA, Ebelt B, Schaefer T, Stuhlmann D, Mehlhorn U, Kuhnregnier F, De Vivie ER, Dhein S: Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. J Am Coll Cardiol 38: 883-891, 2001.
18. Rybin V, Steinberg SF: Thyroid hormone represses protein kinase C isoform and activity in rat cardiac myocytes. Circ Res 79: 388-398, 1996.
19. Severs NJ: Pathophysiology of gap junction in heart disease. J Cardiovasc Electrophysiol 5: 462-475, 1994.
20. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H: Hyperthyroidism and the management of atrial fibrillation. Thyroid 12: 489-493, 2002.
21. Spach MS, Heidlage JF: The stochastic nature of cardiac propagation at a microscopic level. An electrical description of myocardial architecture and its application to conduction. Circ Res 76: 366-380, 1995.
22. Spach MS, Starmer CF: Altering the topology of gap junctions a major therapeutic target for atrial fibrillation. Cardiovasc Res 30: 336-344, 1995.
23. Stagg RB, Flechter WH: The hormone-induced regulation of contact-dependent cell-cell communication by phosphorylation. Endocr Rev 11: 302-305, 1990.
24. Stock A, Sies H: Thyroid hormone receptors bind to an element in the connexin43 promoter. Biol Chem 381: 973-979, 2000.
25. Tribulová N, Varon D, Polak-Charcon S, Buscemi P, Slezák J, Manoach M: Aged heart as a model for prolonged atrial fibrilloflutter. Exp Clin Cardiol 4: 64-72, 1999.
26. Tribulová N, Okruhlicová L, Varon D, Manoach M, Pecháňová O, Bernátová I, Weismann P, Barančík M, Styk J, Slezák J: Structural substrates involved in the development of severe arrhythmias in hypertensive rat and aged guinea pig hearts. Cardiac Remodeling and Failure. NS Dhalla, P Singal (eds), Kluwer Academic Publishers, Boston, 2002, pp 377-398.
27. +-induced ventricular fibrillation while facilitates sinus rhythm restoration in old rats. Exp Physiol 89: 629-636, 2004a.
28. Tribulová N, Shneyvays V, Mamedová KL, Moshel S, Shainberg A, Manoach M, Weisman P, Kostin S: Enhanced connexin-43 and alfa-sarcomeric actin expression in cultured heart myocytes exposed to triiodo-L-thyronine. J Mol Histol 35: 463-470, 2004b.
29. Tribulová N, Dupont E, Soukup T, Okruhlicová L, Severs NJ: Sex differences in connexin-43 expression in left ventricles of aging rats. Physiol Res 54: 705-708, 2005.
30. Wang J, Liu L, Feng J, Nattel S: Regional and functional factors determining induction and maintenance of atrial fibrillation in dogs. Am J Physiol 271: H148-H158, 1996.